In patients with venous thromboembolism and cancer, a low-molecular-weight heparin may be safer than an oral anticoagulant.  This was the conclusion of Dr. Guy Meyer,

מחקר שעקב אחרי 1079 נשים שנותחו בין 1971 ל-1974, כאלה שעברו כריתה מלאה או חלקית, מצא שלא היו הבדלים בשיעורי ההשרדות, חזרה של הגידול בין

Novartis Oncology announced today that Gleevec (imatinib mesylate) has been granted priority review by the U.S. Food and Drug Administration (FDA) for possible use as

NEW YORK (Reuters Health) Aug 19 – An international team of researchers report in the August issue of the European Journal of Cancer that women

LONDON (Reuters Health) Aug 19 – Adding Iressa (ZD1839) to standard platinum-based chemotherapy does not add any survival benefit for patients with non-small cell lung

NEW YORK (Reuters Health) Aug 19 – Treating cancer cells with RNA that is complementary to the messenger RNA corresponding to mutation-flanking regions of DNA

Oral deferiprone appears to be more effective than subcutaneous desferrioxamine for removing iron from the myocardium in patients with beta-thalassaemia.  Researchers measured myocardial iron concentrations

Despite an overall downturn in the risk of developing a solid tumor 25 years after successful treatment of Hodgkin’s disease (HD), long-term survivors remain at

Tumour concentrations of urokinase-type plasminogen activator (uPA) do not predict outcome in patients with breast cancer, but concentrations of uPA inhibitors do.  S. Borstnar and

An injectable gel of cisplatin/epinephrine effectively reduces tumor burden and ameliorates tumor symptoms in patients with squamous cell carcinoma of the head and neck, according

Carboplatin could become a solo first-line chemotherapeutic agent for the treatment of ovarian cancer, according to the latest trial by the International Collaborative Ovarian Neoplasm

Lose-dose oral etoposide appears to be safe and effective for treating refractory or progressed AIDS-related Kaposi’s sarcoma (KS). Investigators from Harvard School of Public Health,

Etoposide plus cisplatin is an effective first-line chemotherapy option for the treatment of patients with metastatic germ cell tumours who have a good prognosis. Researchers

In patients with operable breast cancer, treatment with the antiosteolytic agent clodronate appears to reduce the risk of bone metastases, according to a report published

In men with localized or locally advanced prostate cancer, treatment with the antiandrogen bicalutamide (Casodex; AstraZeneca, Wilmington, Delaware), either alone or as part of a

Low molecular weight heparin (LMWH) should be the preferred choice for preventing recurrent thromboembolism in patients with cancer, according to the results of a randomized

Follow-up of most testicular germ cell cancers may not be necessary after five years because late recurrence is rare. Only patients presenting with metastatic non-seminomatous

Older vegetarians should take vitamin B[12 supplements routinely because vitamin B12 deficiency is associated with anaemia in this patient population, investigators report. They add, however,

A more convenient 22-day course of breast irradiation after lumpectomy for lymph node-negative breast cancer appears to be an acceptable alternative to the 35-day schedule

No environmental factors studied explain the high breast cancer rate seen in Long Island, New York, according to two reports in the August issue of